EMD-13107

Single-particle
2.8 Å
EMD-13107
3D View Gallery
Deposition: 23/06/2021
Map released: 11/08/2021
Last modified: 13/10/2021
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-13107

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 S (Spike) protein in complex with VHH Re5D06 (all RBDs up)

EMD-13107

Single-particle
2.8 Å
EMD-13107
3D View Gallery
Deposition: 23/06/2021
Map released: 11/08/2021
Last modified: 13/10/2021
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Sample: SARS-CoV-2 HexaPro S (Spike) glycoprotein in complex with neutralizing VHH Re5D06

Deposition Authors: Guttler T, Aksu M, Dienemann C, Gorlich D
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies.
Guttler T , Aksu M , Dickmanns A, Stegmann KM , Gregor K , Rees R , Taxer W, Rymarenko O , Schunemann J, Dienemann C, Gunkel P , Mussil B, Krull J, Teichmann U , Gross U, Cordes VC , Dobbelstein M , Gorlich D
(2021) Embo J. , 40 , e107985 - e107985
PUBMED: 34302370
DOI: doi:10.15252/embj.2021107985
ISSN: 1460-2075
ASTM: EMJODG
Grant Support: